MMCAP Infuse RFP for Pharmaceutical Reverse Distribution

Closed State & local contract opportunity Posted

Solicitation number
S-10700-00004591
State
Oregon
Responses due

Opportunity facts

UNSPSC codes
Show all 41

Opportunity details come from oregonbuys.gov. Updated .

About this opportunity

MMCAP Infuse, a governmental cooperative serving state and local government facilities nationwide, has issued a Request for Proposals (RFP) for Pharmaceutical Reverse Distribution services. The procurement seeks qualified national suppliers to process pharmaceutical reverse distribution credits through contracted wholesalers, obtain maximum manufacturer credits, and properly dispose of non-creditable pharmaceuticals. Key deliverables include comprehensive reverse distribution processing that maximizes financial recovery for participating government facilities and ensures compliant pharmaceutical waste management. Potential respondents must demonstrate capability to handle complex pharmaceutical credit and disposal processes across multiple jurisdictions. The RFP timeline includes a question submission deadline of October 14, 2022 at 2 pm Central Time, with questions to be emailed to MMCAP_Infuse.RFP@state.mn.us, and a proposal submission deadline of November 9, 2022 at 2 pm Central Time. MMCAP Infuse anticipates executing an initial two-year contract with potential extension for three additional years, reserving the right to award to a single or multiple contractors.

The RFP demonstrates a preference for Minnesota-certified targeted group, economically disadvantaged, and veteran-owned businesses, suggesting potential set-aside or preference considerations for these business categories. Selected contractor(s) will be required to pay an administrative fee of 3% on all product and service purchases. While no specific budget range is explicitly stated, the cooperative nature of the contract suggests potential for significant transactional volume across multiple government facilities. The procurement appears open to national suppliers with demonstrated expertise in pharmaceutical reverse distribution, emphasizing capabilities in credit processing, manufacturer negotiations, and compliant pharmaceutical waste management. MMCAP Infuse will likely evaluate respondents based on their technical capabilities, pricing structure, proven track record in reverse distribution services, and ability to provide comprehensive solutions that maximize financial recovery and ensure regulatory compliance for participating government entities.

Opportunity text

NOTICE ONLY! MMCAP Infuse RFP 32063 Pharmaceutical Reverse Distribution Q & A due 10.14.2022 2pm CT- MMCAP_Infuse.RFP@state.mn.us RFP due 11.9.2022 2pm CT - MMCAP_Infuse.RFP@state.mn.us See attached for details

Files

File Type Posted
32063-MMCAP RFP_Pharmaceutical Reverse Distribution .pdf PDF
32063Addendum1.pdf PDF
22-0016 Addendum 1~1.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Similar opportunities
  • Ask GovTribe AI about this opportunity